The Descartes Systems Group (NASDAQ:DSGX - Get Free Report) TSE: DSG had its target price lowered by Canaccord Genuity Group from $110.00 to $92.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage currently has a "buy" rating on the technology company's stock. Canaccord Genuity Group's price objective points to a potential upside of 26.46% from the company's current price.
A number of other equities research analysts have also recently commented on DSGX. Zacks Research upgraded The Descartes Systems Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 16th. Morgan Stanley cut their price objective on shares of The Descartes Systems Group from $115.00 to $100.00 and set an "overweight" rating on the stock in a report on Thursday. Raymond James Financial raised shares of The Descartes Systems Group from a "market perform" rating to an "outperform" rating and set a $118.00 price objective for the company in a research report on Thursday, December 4th. Barclays lowered their target price on shares of The Descartes Systems Group from $90.00 to $89.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of The Descartes Systems Group in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $108.64.
Read Our Latest Analysis on The Descartes Systems Group
The Descartes Systems Group Trading Up 5.3%
Shares of DSGX stock traded up $3.65 during trading hours on Thursday, reaching $72.75. 1,095,018 shares of the company's stock were exchanged, compared to its average volume of 763,486. The Descartes Systems Group has a fifty-two week low of $62.56 and a fifty-two week high of $117.35. The stock's 50 day moving average is $74.84 and its 200-day moving average is $86.47. The company has a market cap of $6.26 billion, a price-to-earnings ratio of 41.11 and a beta of 0.77.
The Descartes Systems Group (NASDAQ:DSGX - Get Free Report) TSE: DSG last posted its quarterly earnings data on Wednesday, March 11th. The technology company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The Descartes Systems Group had a return on equity of 10.57% and a net margin of 22.10%.The firm had revenue of $192.37 million during the quarter, compared to analysts' expectations of $188.09 million. During the same quarter last year, the firm earned $0.43 EPS. The business's quarterly revenue was up 15.1% on a year-over-year basis. Equities analysts anticipate that The Descartes Systems Group will post 1.64 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Quarry LP acquired a new stake in shares of The Descartes Systems Group during the third quarter worth about $27,000. Mather Group LLC. purchased a new position in The Descartes Systems Group during the 3rd quarter worth approximately $28,000. Danske Bank A S acquired a new stake in The Descartes Systems Group during the 3rd quarter valued at approximately $34,000. Measured Wealth Private Client Group LLC acquired a new stake in The Descartes Systems Group during the 3rd quarter valued at approximately $40,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of The Descartes Systems Group by 267.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 551 shares of the technology company's stock valued at $52,000 after acquiring an additional 401 shares during the last quarter. 77.73% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting The Descartes Systems Group
Here are the key news stories impacting The Descartes Systems Group this week:
About The Descartes Systems Group
(
Get Free Report)
The Descartes Systems Group Inc NASDAQ: DSGX is a global provider of cloud-based logistics and supply chain management solutions. The company's software-as-a-service platform connects and optimizes the flow of goods, information and payments across the global supply chain, helping businesses coordinate transportation, customs clearance, routing, scheduling and fleet management. Descartes' modular applications serve shippers, carriers, third-party logistics providers and regulatory authorities by enabling real-time visibility, compliance and execution across complex trade networks.
Headquartered in Waterloo, Ontario, Descartes was founded in 1981 and has grown through a combination of organic development and strategic acquisitions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Descartes Systems Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Descartes Systems Group wasn't on the list.
While The Descartes Systems Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.